Rukobia Tablet, Film Coated, Extended Release
Pricing Report NDC 49702-250-18

Current NADAC: $156.58488 per EA · Effective Oct 21, 2026 · Est. package price $9,395.09 (60 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Rukobia (NDC 49702-250-18) is $156.58488 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 21, 2026.

As a a human prescription drug provided by Viiv Healthcare Company, this medication is distributed in a 1 BOTTLE in 1 CARTON / 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$156.58488
Per EA

Effective Date
Oct 21, 2026
Billable Units
60 EA
Estimated Package Price
$9,395.09
Data Status
As of Nov 04, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2024, the NADAC wholesale price for (NDC ) has moved within a range of $145.33050 to $156.86666 per EA. Over this 2 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$145.3305 - $156.8667
Market Volatility
7.94% Variance
Latest Trend
0.16%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 21, 2026 $156.58488 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 23, 2026 $156.83623 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $156.83623 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $156.83624 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 01, 2026 $156.86666 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2026 $156.86666 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2026 $156.86666 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $150.83333 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $150.48500 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $150.46728 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $149.98105 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 20, 2025 $149.89261 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: November 04, 2026